Difficulty: Medium
Average Score: 90%
Practice
You are discussing the risk of radiotherapy with the parents of a child with medulloblastoma; the mother has a concern about the late neurological complications post radiotherapy. The statement that should be included in the discussion that late neurological sequelae post radiotherapy is more severe with
Correct answer
B
Rationale
In pediatric oncology, understanding the impact of radiotherapy on children with brain tumors is crucial. The correct answer, option B, stating that late neurological sequelae post radiotherapy are more severe in children less than 3 years old, aligns with the knowledge that younger children have developing brains that are more vulnerable to the effects of radiation.
Option A is incorrect because craniospinal irradiation, while encompassing a larger area, is associated with more acute rather than late neurological complications. Option C, concomitant chemo-radiotherapy, may increase the overall toxicity but doesn't specifically correlate with increased late neurological sequelae. Option D is incorrect as the severity of late neurological sequelae is not determined by tumor grade.
Educationally, this question underscores the importance of considering age as a factor in the risk assessment of late effects of radiotherapy in pediatric patients with medulloblastoma. It highlights the need for personalized treatment approaches based on age-related vulnerabilities in pediatric oncology. Understanding these nuances can help healthcare providers tailor discussions with parents to address concerns and make informed treatment decisions.
Option A is incorrect because craniospinal irradiation, while encompassing a larger area, is associated with more acute rather than late neurological complications. Option C, concomitant chemo-radiotherapy, may increase the overall toxicity but doesn't specifically correlate with increased late neurological sequelae. Option D is incorrect as the severity of late neurological sequelae is not determined by tumor grade.
Educationally, this question underscores the importance of considering age as a factor in the risk assessment of late effects of radiotherapy in pediatric patients with medulloblastoma. It highlights the need for personalized treatment approaches based on age-related vulnerabilities in pediatric oncology. Understanding these nuances can help healthcare providers tailor discussions with parents to address concerns and make informed treatment decisions.